Rule CG-CSR-001
Regulatory status: what rule CG-CSR-001 checks
Rule CG-CSR-001 is one of the checker's regulatory status rules. It cites 21 CFR 1306.04, 21 U.S.C. 829 and more. The reason, source and safer wording are below.
CG-CSR-001 · Blocks approval · Citation checked against stored text
Prescribing a controlled substance without a real evaluation, records or follow-up violates the Controlled Substances Act and DEA telemedicine rules.
Source: 21 U.S.C. 829 and 841(h); 21 CFR 1306.04 (prescription issued for a legitimate medical purpose); 21 CFR 1306.05 (manner of issuance, so a prescription must carry the patient and practitioner details); FTC Act section 5
Safer wording: Do not advertise controlled substances. A licensed clinician must decide whether to prescribe after a real evaluation.
21 CFR 1306.04, 21 U.S.C. 829, 21 CFR 1306.05 · Needs counsel review
Next step
Check your copy against this rule
Run the checker and every flag cites its rule and source.